Comparison between Asston Pharmaceuticals IPO and Yajur Fibres IPO.
Asston Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Yajur Fibres IPO is a SME Bookbuilding proposed to list at BSE SME.
| Asston Pharmaceuticals IPO | Yajur Fibres IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | MAS Services Ltd. |
| Market Maker | JSK Securities & Services Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Asston Pharmaceuticals IPO is up to ₹26.17 Cr whereas the issue size of the Yajur Fibres IPO is up to ₹114.38 Cr. The final issue price of Asston Pharmaceuticals IPO is ₹123.00 per share and of Yajur Fibres IPO is ₹174.00 per share.
| Asston Pharmaceuticals IPO | Yajur Fibres IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹115.00 per share | ₹168.00 per share |
| Issue Price (Upper) | ₹123.00 per share | ₹174.00 per share |
| Issue Price (Final) | ₹123.00 per share | ₹174.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 800 shares |
| Fresh Issue Size | 21,28,000 shares | 65,73,600 shares |
| Fresh Issue Size (Amount) | up to ₹26.17 Cr | up to ₹114.38 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,28,000 shares | 65,73,600 shares |
| Issue Size Total (Amount) | up to ₹26.17 Cr | up to ₹114.38 Cr |
Asston Pharmaceuticals IPO opens on Jul 09, 2025, while Yajur Fibres IPO opens on Jan 07, 2026. The closing date of Asston Pharmaceuticals IPO and Yajur Fibres IPO is Jul 11, 2025, and Jan 09, 2026, respectively.
| Asston Pharmaceuticals IPO | Yajur Fibres IPO | |
|---|---|---|
| Anchor Bid Date | Jul 08, 2025 | |
| Issue Open | Jul 09, 2025 | Jan 07, 2026 |
| Issue Close | Jul 11, 2025 | Jan 09, 2026 |
| Basis Of Allotment (Tentative) | Jul 14, 2025 | Jan 12, 2026 |
| Initiation of Refunds (Tentative) | Jul 15, 2025 | Jan 13, 2026 |
| Credit of Share (Tentative) | Jul 15, 2025 | Jan 13, 2026 |
| Listing date (Tentative) | Jul 16, 2025 | Jan 14, 2026 |
| Anchor Lockin End date 1 | Aug 13, 2025 | |
| Anchor Lockin End date 2 | Oct 12, 2025 |
Asston Pharmaceuticals IPO P/E ratio is 17.83, as compared to Yajur Fibres IPO P/E ratio of 23.49.
| Asston Pharmaceuticals IPO | Yajur Fibres IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Asston Pharmaceuticals Ltd.'s revenue increased by 62% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 68.76 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 50.66 | 69.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.83 | 23.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹104.70 Cr. | ₹394.68 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.56% | 26.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 51.25% | 17.14% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.68 | 1.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.90 | ₹7.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 40.36% | 27.59% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Asston Pharmaceuticals IPO Retail Individual Investors (RII) are offered 7,46,000 shares while in Yajur Fibres IPO retail investors are offered 7,46,000 shares. Qualified Institutional Buyers (QIB) are offered 4,25,000 shares in Asston Pharmaceuticals IPO and 64,000 shares in Yajur Fibres IPO.
| Asston Pharmaceuticals IPO | Yajur Fibres IPO | |
|---|---|---|
| Anchor Investor Reservation | 6,35,000 shares | 0 shares |
| Market Maker Reservation | 1,13,000 shares | 3,46,400 shares |
| QIB | 4,25,000 shares | 64,000 shares |
| NII | 3,22,000 shares | 19,51,200 shares |
| RII | 7,46,000 shares | 45,58,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 21,28,000 shares | 65,73,600 shares |
Asston Pharmaceuticals IPO subscribed 186.55x in total, whereas Yajur Fibres IPO subscribed 1.33x.
| Asston Pharmaceuticals IPO | Yajur Fibres IPO | |
|---|---|---|
| QIB (times) | 85.76x | 1.03x |
| NII (times) | 353.14x | 0.91x |
| Big NII (times) | 424.47x | 0.87x |
| Small NII (times) | 210.85x | 1.00x |
| RII (times) | 172.06x | 1.51x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 186.55x | 1.33x |
